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We have recently demonstrated an important fuhc-
tion of keratinocyte growth factor (KGF) in morpho-
genesis of epithelium and wound re-epithelializa-
tion. Furthermore, abnormalities in KGF expression 
or responsiveness are associated with wound-healing 
defects . In this study we have analyzed the regulation 
of KGF expression during wom1d repair in glucocor-
ticoid-treated mice that are characterized by severe 
w ound healing abnormalities. Induction of KGF 
mRNA expression after skin injury was significantly 
reduced in these tnice, whereas KGF receptor mRNA 
levels were only affected to a minor extent by glu-
cocorticoid treatment. The reduced KGF expression 
during wound healing in steroid-treated animals is at 
I Recently we demonstrated a large induction of 
keratin. ocyte gro\. >vth f.1ctor expression in the der-
mis upon skin injury in nonnal mice [1]. High 
levels ofkeratinocyte growth factor (KGF) mRNA 
were detected in dermal fibroblasts below the ( 
wo und and at the wound edge already within 24 h after wounding. 
This finding suggested that dermally derived KGF stimulates 
wo und re-epithelialization in a paracrine manner. This hypothesis 
was proved in a transgenic mouse model, where a blockade ofKGF 
~ receptor signaling in basa l keratinocytes of the epidermis inhibited 
wound re- epithelialization [2] . Furthermore, we were able to 
demonstrate that wound-healing abnormaLities as seen in geneti-
cally diabe tic db/ db mice are associated with reduced expression of 
KGF and its receptor during skin repai r [3] . T he db/ db mice 
developed obesity, insulin res istance, and severe hyperglycemia 
resembling adu lt onset diabetes melli tus [4]. Wound healing in 
these mice is markedl y delayed but can be reversed by topica l 
application of growth fa ctors such as plate let-derived growth f.1ctor 
and several members of the fibroblast growth factor family [5-7]. 
Thus it seems likely that the corresponding endogenous growth 
fac tors might be limited during tissue repair as demonstrated for 
KGF. This mitogen is a member of the fibroblast growth f.'l ctor 
(FGF) family , which includes acidic FGF (aFGF, FGF-1), basic FGF 
(bFGF, FGF- 2), int-2 (FGF-3) , hst (FGF-4), FGF-5 , FGF-6, KGF 
(FGF-7) [8] , androgen-induced growth h1ctor (AIGF, FGF-8) [9], 
and g lia-activating factor (FGF-9) [10]. These facto rs are potent 
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least partially due to a direct effect of glucocorticoids 
on the KGF expressing n1esenchymal cells, because 
treatment of cultured fibroblasts with dexametha-
sone reduced KGF mRNA levels in a time- and 
concentration-dependent manner. The inl1ibitory ef-
fect of glucocorticoids on KGF expression was com-
pensated for by high levels of serum growth factors 
or pro-inflammatory cytokines, demonstrating that 
KGF expression is subject to positive and negative 
regulation. Thus it seems likely that a fine balance of 
various KGF-regulating factors is important for nor-
mal wound healing. KeJ' rvo1•ds: KGF l'eceptorlde.\:ametlr-
asouelrvormd l'epail'.] ltwest Derma.to/105:579-584, 1995 
mitogens and chemotac tic agents i11 JJitro for many ce Ll s of mesen-
chyma.! and epithel ial origin, but they can also be involved in 
differentiation processes [8] . KGF differs from the other members of 
the FGF f.·unily by its high specificity for keratinocytes (11-13)- It 
was shown to be expressed in cells of mesenchymal origin, e.g., 
fibroblasts [12] and microvascular endotllClial ce lls [1 4], but not in 
epithelial ce lls. 
In this study we have an alyzed a possible role ofKGF in another 
model for impaired wound hea ling, the glucocorticoid-treated 
mouse. A series of experiments and clinica l studies suggest that the 
prolonged administration of anti-inflammatory steroids leads to a 
delay in wound repair and an increase in loca l wound complications 
[15, 16]. The wound-healing defects in glucocorticoid-treated ani-
mals can be reversed by exogenous application of various growth 
factors, e.g., basic FGF [7] or transfo rming growth factor {31 
[17,18], suggesting that these mitogens might be present in limited 
amounts in the wound . Here we show that g lucocorticoid treat-
ment of tnice leads to reduced KGF induction afte r cutaneous 
injury . Furthermore we demonstrate that this effect is at least 
partially due to a direct inhibitory effect of glucocorticoids on the 
KGF-producing mesenchymal cells. 
MATEIUALS AND METHODS 
Glucocorticoid Treatment of Mice For each experiment. seven fe-
ma le Balb/c mice (3 months old) were injected subcmancously at 9 A.M . 
daily with 1 mg dexamethasone per kg bod)' weight for 7 d . Seven control 
mice were ir~ ccted with phosphate-buf!'e red sa line. Three dexamethasone-
trea ted 111icc and three contro l rni cc were subsequently injec ted \Vith 
dexamethasone or phosphate-buffered sa line for another 3 d but left 
unwounded. The other mice were wounded as described below . During the 
\vound-hcaling perio d rhc dail y injection of dcxaincthaso nc. or phosphntc-
buflcred saline was continued. 
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Wounding and Preparation of Wound Tissues Three independent 
wound-hea ling experiments were performed. For each experiment, four 
dexa methasone-treated mice and four control mice were anesthesized w ith 
a si ngle intraperitonea l injection of avertin. T he hair on the back of these 
mice was cut with fine scissors and the back was subseq uently w iped with 
70'Y,, ethano l. Six full-th ickness wounds (6-mm diameter, 3-4 mm apart) 
were made on the back of these mice by excising the skin and pm111irul11s 
cnmos11s. T he wounds were allowed to dry to form a scab. Animals were 
sacrifi ced and \Vounds 'vcrc harvested at dc:iy 2 or 3 after \.voundi.ng. An area 
of7-8 mm in diameter, which incl udes the complete epithe li al margins, was 
excised at each time point. A similar amount of skin fi·om the backs of three 
non-wounded anin1a ls was used as a controL In every expcrin1 ent, the 
wounds from four animals (24 wounds) and the non-wounded back skin 
fro m three anima ls were combined. immediately frozen in liquid nitrogen 
and stored at - 70°C until used for RNA isolation. In one experiment, e ight 
add itional mice (four control mice and four glucocorticoid-treated mice) 
were wounded. The wounds of tlwse mice were ana lyzed histologically at 
day 3 or 5 afte r injury to stud y the efFects of glucocortico id treatment o n 
wound hea ling. All animal experiments were ca rricd out with permiss ion 
from the loca l government of Bavaria (pennission number 211-2531-1 6/ 
93). 
Histology Gl ucocorti coid-treated mice and control mice were wounded 
as described above. Animals were sacrifi ced at day 3 o r 5 after injury. 
Complete wounds were isolated from the middle of the back, bisected, 
fixed oven"light in 41!/o paraformaldchyde, and paraftln embedded . Six-
micrometer sections from the middle of the wound were sta ined w ith 
hciniltoxylin/ eos in . 
Cell Culture Murine Balb/c3T3 fibroblasts were cu ltured in Dulbecco 's 
modified Eagle ' s medium (DMEM) with 10% feta l bovine se rum (FBS). For 
experiments with quiescent fibrob lasts, cell s were grown to conHuency 
without changing the medium and rcndered quiescent by a 16-h incubation 
in DMEM/ 1% FJ3S. After a 2-h incubation in serum-free DMEM, 
dexamethasone was addcd to the medium. Cytokines and /or newborn 
bovine se rum (NBS) were added 1 h later. For experiments with exponen-
tia lly growing fib roblasts, ce ll s were grown in DMEM/'1 0% FBS for 3-4 d 
unti l they were 70'X• confluent . T hey were subsequentl y treated with 
dexamethasone·. cytokines, and NBS as described above without changing 
the medium . AJiquots of cells were harvested before and at different time 
points after addition of these reagents. Total cellular RNA was isolated from 
these cells and used for R.Nasc protection assays. Each experiment was 
repeated at least tw ice . 
I' J3S, NBS, and DMEM were purchased from Gibco/BR.L, growth factors 
and cytokines were from Boehringer Mannheim Biochemicals, and dcxa-
mcthasone was from Sigma Biochemical s. 
RNA Isolation and RNAse Protection Assay RNA iso lation was 
performed as described [19). Twenty micrograms of tota l RNA li·om 
c ultured cells or 50 /..Lg tota l J~NA fron1 wounded or non-wounded skin 
were used for R.Nase protection assays. l~asc protection assays were 
carried o ut as recently described 1"1 ]. UrieAy, DNA probes were cloned into 
the transcription vecto r pBluescript KSII (+ ) (Stratagene) and li nearized. 
An antisense transcript was synthesized i11 11 ilro using T3 or T7 RNA 
polymerase and 32P-UT P (800 Ci/mmol). Samples of 20 o r 50 jl.g I~ A 
were hybridized at 42°C overnigh t with 100,000 cpm of the labeled 
antisense transcript. Hybrids were digested with l~ase A and T 1 for 1 h at 
30°C. Protected fragments were separated on 5°/o, acrylamide/8 M urea ge ls 
and analyzed by autorad iography. A riboprobc complementary to nucleo-
tides 23-224 of the murine KGF eD NA J20] was used as a probe for the 
detection of KGF mR.NA. KGF reccptor mR.NA was detccted by a 
32P-labelcd probe corresponding to nucleotides 831-1102 of the eDNA 
encoding the KGF receptor variant of FGFR2 [1 3]. 
Northern Blot Analysis Northern blot experiments were performed as 
described [21] . Samples of I 0 IL£ tota l cellular RNA were fractionated on a 
vertica l ·t % agarose/6% formaldehyde gel and transferred to Gcnc sc reen 
plus nylon membrane (NEN , Boston , MA). A 32 P-labelcd 200-bp eDNA 
fragme nt corresponding to nucleotides 23-224 of the mtn·ine KGF eD NA 
[20] was used as a hybridization probe . 1-lybridization was ca rried out under 
high-stringency condi tions (42°C, SO'Y,. formamide) to avoid cross-hybrid-
ization with other members of the FGF f:nnil y. As a contro l. the fi lter was 
re-hybridizcd with probes specific for /3-actin o r /31 integrin. 
R.ESULTS 
Induction of KGF Expression After Injury Is Reduced in 
Glucocorticoid-Treated Mice Dexam e thasone was injected 
daily at 9 A.M. over a period of 7 d b efore wounding and 2-5 d 
T H E JOUI~NAL 0 1' INVESTIGATIVE DERMATOLOGY 
-
F igure 1. Reduced granulation tissue formation and re-epithclial-
ization in 5-d wounds of glucocorticoid-treated mice. Full-tllickness 
wounds were made on the backs of control mice (Ctr) and glucocorticoid-
treated mice (Dex). Mice were sacrificed at day 5 after inju ry. Wounds from 
the same location were isolated, bisected, li xcd in 4% paraformaldchydc. 
and paraffin embedded. Sections from thc middle of the wound were stained 
\Vith hcn1atoxy lin /eos in . E, cpitheliunt at the wound edge ~ G , g ranulation 
tissue; Es, eschar. Swle bnr, 1 00 Jl.m. 
after wounding. To prove th e d e leterio u s effect of dexamethasone 
t reatm e nt on wound repair, wounds were ana lyzed l~isto logi call y ar 
days 3 and 5 after injury. As sh own in Fig 1, a significant amoum 
of granula t io n tissue h ad formed in con tro l mice at day 5 after 
injury, whereas in dexamethasone-treated mice granulation tissue 
format io n was hardly detectable . Furthe rmore, re-epithclialization 
was dramatically delayed in g lucoco rt icoid-treated mjce, su ggesting 
that KGF expression might b e reduced in these animals. To test this 
possibility, RNA was isolated !Tom non-wounded and wounded 
ski n of g lucocorti coid-treated mice and control mice at day 2 or 3 
after injmy and analyzed for KGF mRNA express io n. In n on-
wounded skin of contro l mice and g lucocorticoid-tr eated mice 
KGF mR .. NA express io n was ve ry low, as was evident from the 
exposure time of the protection assay (Fig 2A) . H owever, a large 
indu ction of KGF mRNA expression occua:re d within 3 d after 
injury in con t ro l mice (55- o r 65-fold, respectively), bur n ot in 
dexamethasone-treated mice (Fig 2B) . In th ese mice, KGF mR.NA 
levels in creased on ly 10-13-fold. A similar difference b etween 
contro l mice and g lucoco rticoid-tre ate d mice occurred at day _ 
after wounding (data not shown) . T h ese i11 Pillo data demonstrate 
that g lucocor ticoids reduce the n o rmal induc tion of KGF expre-
sio n afte r c utan eou s injury . 
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, Figure 2. Induction of KGF mRNA expression is significantly reduced during wound healing in glucocorticoid-treated mice. Balb/ c mice 
were treated with glucocorti coids as described in i\lntcrinls n111l Methods. Mice injected wi th phosphate-buffe red saline were used as a control (ctr). l"l..NA w as 
isolated from (A ) non-wounded skin and (B) wounded skin (3 d alte r wounding) o f contro l mice and dexamethasone-treated (Dex) mice. Jn every 
experiment, non-wounded skin and wounds were pooled and used for RNA isolation . Fift)' micrograms of cow l cellular RNA fi·om two independent 
experiments ( I ;111d 2) were analyzed by R.Nase protection assay fo r KGF express ion. Five hundred to one thousand coun ts per minu te of the hybridization 
probe were used as a size marker. The R Nase protection assays were exposed fo r 40 It (A} and 12 h (B). An cthidium bromide stain of I J.Lg of the same 
1 batch of RNAs is shown in (C) . 
G lucocorticoids Have Only Minor Effects on KGF Receptor 
Expression in Non-Wounded and Wounded Skin To stud y 
w h e th er g lu co co rti co id treatment al so aflects KGF recepto r expres-
sion. RN A samples fro m th e sam e expe riments were h ybridized 
• w ith a pro be co mpl e m e n ta ry to the KGF re ce p to r D N A. In 
non-wo unde d skin , g lu cocorti co id t reatment had n o e flcct o n the 
1 
expressio n le vels o f KGF receptor mR.NA (Fig 3A ). K G F recep to r 
mR.NA leve ls were 20 - 35% lo w e r in 2-d and 3-d wounds o f 
dexam e thasone-treated mice compare d to control mi ce (Fig 3B 
and d ata not sho wn) . T his reduc tio n w as mu ch less severe co m -
pared to th e reductio n in K GF mRN A levels (70- 80%). 
Glucocorticoids Reduce KGF mRNA Levels in Cultured 
Fibroblasts in a Tilne- and Concentration-Dependent Man-
ner Th e sig nifi can t reduc ti o n o fKG F expressi o n in wounde d skin 
of d exa methasone-treated mice suggeste d a direct e ffect of g lt; -
coco rti coid s o n the KG F- produc ing m esen ch ymal ce ll s. To address 
this questio n , expo ne n tia ll y g ro wing murine B alb /c 3T3 fi bro blas ts 
wer e treated with dexam e tha sone fo r diflc re n t t im e pe rio ds . As 
sho wn in Fig 4, hig h levels o f KGF mRN A were detected in 
e xpo n e ntia ll y g rowing fi b roblasts , but 4 h afte r addi t io n of dexa-
m e th ason e, KG F expressi o n had alm ost di sappeared. A similar 
inhibi to ry effect o f d e xam e tha son e w as seen in primary human skin 
f:ibro blas ts (da ta no t sh own) . Inhibitio n o f KGF expressio n by 
d exam e thasone occurre d in a concentratio n-de pe ndent mann e r, 
and a maximal respo nse was o bserved at a concentra t io n of 1 fLM 
dexam etha sone (Fig 5) . Beca use these concen tratio ns correspo nd 
to the appro pri ate pharmacologic rank o rde r of po te n cy. the e ffect 
of d exam e thason e o n K G F expressio n m ay be m edia te d b y the 
glu cocor ticoid receptor. 
Positive Regulators of KGF Gene Expression Compensa te 
for the Negative Regulation by Glucocorticoids We and 
o th e rs have recentl y d e m o nstrate d a positive regul ati o n o f K G F 
expressio n b y serum g ro wth f:J c to rs and pro -inflammato ry cy to-
kines [22,23] . B ecause K GF express io n is n o t comple te ly down-
re g ulated b y d exa m ethasone during wound healing, w e specul ated 
tha t these f.<ctors can at least partiall y com pensa te fo r the inhibi tory 
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Figure 3. Glucocorticoids have only minor effects on KGF receptor 
mRNA expression during wound healing. T he expression of KGF 
receptor rnR.NA in non-wounded skin (A) and wounded skin (B) of normal 
and glucocorticoid-trc:~tcd mice was analyzed as described in the legend of 
Fig 2. The same !WAs (50 /Lg) were used for the KGF and the KGFR 
protection assays. f ive hundred to one thousand counts per minute of the 
hybridi zation probe were used as a size n1arkcr. T he protectio n assays were 
exposed for 16 h (A) and 22 h (B). 
effect by g lucocorticoids. To test this poss ibili ty, we treated expo-
nentially g rowing fibroblasts with a combination of dexametha-
sone , tumor necrosis factor alpha (TNF-a) , interleukin-l ,B (IL-1/3), 
o r NBS, respective ly. T hese pro-inAammatory cytokines have been 
shown to be potent stimulato rs of KGF express ion in fibroblasts 
(22]. As showi1 in Fig 6, high concentn1tions o fTN F-a (300 U/m l) 
completely reversed the negative regu la tion by dexamethasone and 
a partial compensation was obtained with 100 U/ml IL-1 ,B. The 
same compensatory effect was o bta ined w ith 10% NBS and platelet-
derived growth factor BB (data not shown), which are also positive 
regu lators of KGF expression [22,23 ]. In contrast to exponentially 
g row ing fibroblasts, quiescen t fibroblasts express only low levels of 
KGF mRNA [22]. However, expression of KGF mR.NA is rapidly 
stim ulated in these ce lls by factors that stimulate cell proli feration 
(22] . T he low levels of KGF mRNA seen i.n quiescent fibroblasts 
were further reduced by addition of dexamethasone (Fig 7) . 
However, addition of the gl ucocorticoid did not inhibit induction 
of KGF mRNA expression by se rum and TNF-a (Fig 7) . T hese 
find ings demonstrate that the inhibitory eftect of glu cocorticoids on 
KGF express ion ca n be reversed by positive regula to rs of the KGF 
gene and thus might provide an explan ation fo r the beneficial effect 
of exogenous g rowth factors on wound healin g in glucocortico id-
treated mice . 
DISCUSSION 
lnhibition of wound healing by corticosteroids is a well-known 
phenomenon [15] that may be due to the suppression of the 
inAammatory phase of healing by inhibi ting leukocyte and m acro-
phage infiltration [24 -26] but also to the direct inhibition of genes 
in volved in wound hea lin g. T hus it has been shown that t he mRNA 
expression of collagen type I is inhibi ted by glucocorticoids (27] , 
and we have recentl y demonstrated a negative effect of th ese 
steroids on tenascin expression i11 11 i11o (RF and SW, unpublished 
data). In contrast to corticosteroids, several growth facto rs are 
potent promoters of the healing process (28]. T hus, recent studies 
demonstrated that administration of transforming growth factor ,131 
or members of the fibroblast growth f.,ctor fa m.il y can reve rse th e 
impaired wound healing ca used by aging, metabolic disorders, or 
glucocorticoid treatment [17, 18,29). T hese findings suggest t hat 
some growth facto rs could be present in limited amou nts in a 
poorly healing wound . T lus has recently been shown for KGF 




Figure 4. Inhibition ofKGF mRNA by dexam e thasone in cultured 
murine fibroblasts. Exponentially growing Balb/c 3T3 fibrob lasts were 
treated with 100 nM dexamethasone (Dex) for different time periods as 
indicated. Ten micrograms of total cellular IWA from these cells were 
ana lyzed for KGF mlWA express ion by Northern blot analysis using a 
32P-Iabeled murine KGF eDNA. The fi lter was exposed for 4 d. As a loading 
control , the same filter was rc-hybridizcd with a 32P-Iabcled /3-actin and a 
32P-Iabeled /31 intcgrin probe. 
expression, which is significantly indu ced during wound repa ir in 
no rmal mice but not in genetica lJ y diabetic mice [3]. Furthe rmore, 
inhibition of KGF receptor function in the epidermis of transgen.ic 
mice resulted in epide rmal atrophy and delayed wound re- epithe-
lialization (2]. Given the inhibititory effect of g lucocorticoids on 
keratinocyte proliferation i11 11itro (30] and the reduced re- epitheli-
alization i11 11 i1'0 (Fig 1), we spec ula ted that the no rmal ind uction of 
KGF expression after skin injury might also be reduced in g lucocor-
ticoid-treated •n ice, and this was clearly demonstrated by the 
expet;ments described in tlus study. T his finding provides a mo-
lecular explanation for the inhibi tion of epi the lial regen eration by 
g lucocorticoids that leads to a thinned, abnormal epidermis. 
In addition to KGF, express ion of KGF recepto r mRNA was also 
lower in the wounds of glucocorticoid-treated mice compared to 
contro l mice. H owever, this reduction was mu ch less d ramatic 
compared to reduction of KGF mRN A expression . Furthermore, 
the reduced expressio n of KGF receptor mRNA in the wounds of 
dexamethasone- treated mice is clearly not due to a direct effect of 
g lucocorti coids on the KGF receptor expressing keratinocytes, 
beca use treatment of cultured keratinocytes with differen t concen-
trations of dexamethasone had no effect on KGF receptor expres-
sion (data not shown). In contrast, the sligh t reduction visible in 
dexamethasone-treated wounded skin could be due to a lower 
percentage ofkeratinocytes in the wound tissue after g lucocorticoid 
treatment, reAecting the reduced re- epithe lial.ization seen in these 
m1ce . 
T h e inhibitory effect of glucocorticoids on KGF ex pressio n might 
be the result of an inhibi tion ofKGF-inducing f.1cto rs in the wound 
but also of a direct effect of these steroids on the KGF-producing 
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Figure 5. Inhibition ofKGF 1nRNA expression by dexamethasone 
occurs in a concentration dependent tuanncr. Exponentiall y growin g 
Balb/c 3T3 fibroblasts were treated for 24 h with difrc rent concentrations of 
dexamethasone (Dex) as indicated. A) 20 JLg tota l ccUular RNA from these 
cells were analyzed for KGF m!\.NA expression by R.Nase protection assay. 
One thousand counts per minute of the hybridization probe were used as a 
size marker. Fifty micrograms of tR.NA were used as a control. B) 
Schemati c representation of the dose-dependent cfrcct of glucocorticoids on 
KGF rnRNA expression in exponentially growing lla lb/c 3T3 fibroblasts. 
KGF rnRNA expression was analyzed by R.Nase protection assay and 
quantitated by laser scanning densitometry. The concent ration of dexa-
meth asone (nM) is indicated below the bnrs. 
' tured fibrob lasts by dexamethason e suggested that a direct e ffec t of 
glucocorticoids on m esen ch ymal ce lls mig ht be at leas t partiall y 
respon sibl e for the redu ced induction of KGF e xpression during 
wound h ealing. However, indirect m echanism s might also contrib-
ute to this effect. Thus, we and others h ave recently de monstrated 
a positi ve effect of several growth f.1ctors and pro-inAammatory 
cytokines o n KGF expression [22,23 ] . Tn parti cularly, factors that 
are produced by polymo rphonuclea r leukocytes o r m acro phages, 
e .g. , plate let-derived growth factor, transforming growth factor 0', 
IL-1/3, lL-6, and T N F [31-39] arc po te nt inducers of th e KGF gene . 
Polymorphonuclear leu kocytes and macrophages are the predom-
inant ceU types of the ea rl y in flammatory respon se during repair and 
infiltrate the w o und area within 6 -72 h afte r injury. Activated 
macrophages subse qu entl y initiate g ranul ation-t issue fo rmati o n and 
remain present in the wound ti ssue even beyond the initial inAam-
matory ph ase [39 ,40]. T he a.ltered differentiation of monocytes into 
macrophages and the reduced infi ltration of le ukocytes and mac-
rophages in to the woun d site after g lucocorticoid treatment might 
result in a lack of KGF-inducing facto rs in the wound. T his 
hypoth esis is supported by preliminary d ata fro m o ur labo rato ry 
that d em o n strate redu ced levels of T NF-a and IL-1 J3 mRN A in 
wound tissue of de xamethason e- treated mice (G. Hubner and M . 
Bra u ch.l e, unpublished data) . T hu s, a combination of direc t and 
indirect effects are li ke ly to contribute to th e reductio n o f KGF 
mRNA levels during woun d h ea ling in steroid-treated animals. 
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Figure 6. The eflcct of dexamethasone on KGF mR.NA expression 
can be compensated for by growth factors and pro-inflammatory 
cytokincs in exponentially growing fibroblasts . Exponentia ll y grow-
ing 13alb/c 3T3 fib roblasts were treated with 100 nM dexamethasone (Dcx) 
(dissolved in ethanol) or \·\~th the solvent ethanol (EtOH). O ne hour after 
addition of dexamethasone. I 00 U/ ml IL-1 f3 and 300 U / ml TN F-a were 
added as indicated. After a 2-b incubation period tota l cellular RNA was 
iso lated from these cell s. Twenry micrograms of RNA were analyzed by 
R.N Ast! protection assay for KGF mR.NA expression. Fifty micrograms of 
tl~ A were used as a control. O ne tho usand coun ts per tninu tc of the 
hybridization probe wl!rc used as a size marker. 
A ltho ugh KGF mR.NA leve ls are sig nificantly reduced by g lu-
cocorti coids in cu ltured fi bro blasts, KGF mRNA induction was not 
completely abolished afte r injury in dexamethasone-treate d mice. 
This fi nding suggested that pos itive regula to rs of KGF gen e 
expression mig ht at least partia lly compen sate the inhibito ry effect 
of th e g lu cocorticoid . This hypoth es is was supported by o ur iu r1irro 
studies, which demonstrated a complete reversal of th e inhibi to ry 
e ffect of d exam eth ason e by h igh con centrations of positive regu la-
tors of KGF gen e express ion. T hu s it seems like ly th at the actual 
degree ofKGF induction afte r skin injury d ep ends o n the avai labi l-
ity of posit ive and negative regulators of KGF gen e expression at 
the wound site. Most importantly, this finding provides a m o lecular 
C:\.-planation for the b en efic ial effect of high con centration s of 
exogen o u s g ro w th factors o n wound repair in g lucocorticoid-
treated animals. 
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Figure 7. The effect of dexamethasone on KGF mR.NA expression 
can be cotnpensatcd for by growth factors and pro-inflammatory 
cytokincs in quiescent fibroblasts. Scrum-sr:1rved 13alb/c 3T3 fi bro-
blasts were treated with I 00 nM dexamethasone I dissolved in l!thanol 
(EtOH)J or w ith tlw solvent ethanol. Afte r a · 1-h incubation period . 300 
U/ ml TN F-a or 10% NllS were added as ind ica ted. After an add itional 2-h 
incubation peri od, to tal cellular R.N.A was isolated from tlwse cells. Twt!nty 
rnicrogr:m1 s of 1\...NA were an alyzed by R.Nase protectio n an~ lys is fo r the 
express ion of KGF mH.NA. 
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